Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 14, 2023

Effect of Extended Anastrozole Treatment After 5 Years of Initial Anastrozole-Containing Therapy in Patients With Hormone Receptor–Positive Breast Cancer

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial
J. Clin. Oncol 2023 Apr 20;[EPub Ahead of Print], T Iwase, S Saji, K Iijima, K Higaki, S Ohtani, Y Sato, Y Hozumi, Y Hasegawa, Y Yanagita, H Takei, M Tanaka, H Masuoka, M Tanabe, C Egawa, Y Komoike, T Nakamura, H Ohtsu, H Mukai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading